uniQure (QURE) Change in Account Payables (2016 - 2026)
uniQure (QURE) recorded quarterly Change in Account Payables of -$557000.0 in Q1 2026, up 45.34% quarter-over-quarter from -$1.0 million in Q4 2025, and up 73.39% on a YoY basis from -$321245.8 in Q1 2025.
uniQure (QURE) Change in Account Payables (2016 - 2026) Analysis & Trends
uniQure's Change in Account Payables history runs 11 years deep, the most recent figure standing at -$557000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 73.39% year-over-year to -$557000.0; the TTM figure through Mar 2026 stood at -$1.1 million (down 983.59% YoY), while the FY2025 annual figure was -$2.7 million, down 275.46% from the prior year.
- Change in Account Payables was -$557000.0 for Q1 2026 at uniQure, up from -$1.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $7.3 million in Q1 2022 to a low of -$3.6 million in Q3 2023.
- Historically, Change in Account Payables has averaged $197941.2 across 5 years, with a median of -$204000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables surged 272.49% in 2022, then tumbled 304.45% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $4.7 million in 2022, then slumped by 86.94% to $615000.0 in 2023, then soared by 230.41% to $2.0 million in 2024, then tumbled by 150.15% to -$1.0 million in 2025, then soared by 45.34% to -$557000.0 in 2026.
- The last three Change in Account Payables figures came in at -$557000.0 (Q1 2026), -$1.0 million (Q4 2025), and $649000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -557,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -557,000.00 |
| Mar 31, 2026 | -557,000.00 |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | 649,000.00 |
| Sep 30, 2025 | 649,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | -2.09 Mn |
| Mar 31, 2025 | -2.09 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | -918,000.00 |
| Jun 30, 2024 | -918,000.00 |
| Mar 31, 2024 | -701,000.00 |
| Mar 31, 2024 | -701,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Dec 31, 2023 | 615,000.00 |